Haemonetics (HAE) Competitors $84.92 +0.09 (+0.11%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends HAE vs. ALGN, MMSI, ICUI, XRAY, NEOG, QDEL, STAA, CERS, OSUR, and ANIKShould you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Neogen (NEOG), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry. Haemonetics vs. Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Neogen QuidelOrtho STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Align Technology (NASDAQ:ALGN) and Haemonetics (NYSE:HAE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation. Which has preferable valuation and earnings, ALGN or HAE? Align Technology has higher revenue and earnings than Haemonetics. Haemonetics is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$3.96B4.22$445.05M$5.8638.20Haemonetics$1.36B3.13$117.56M$2.4135.24 Is ALGN or HAE more profitable? Align Technology has a net margin of 11.15% compared to Haemonetics' net margin of 9.10%. Haemonetics' return on equity of 22.67% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology11.15% 13.99% 8.53% Haemonetics 9.10%22.67%8.83% Does the MarketBeat Community prefer ALGN or HAE? Align Technology received 391 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 69.72% of users gave Align Technology an outperform vote while only 61.25% of users gave Haemonetics an outperform vote. CompanyUnderperformOutperformAlign TechnologyOutperform Votes78369.72% Underperform Votes34030.28% HaemoneticsOutperform Votes39261.25% Underperform Votes24838.75% Do analysts prefer ALGN or HAE? Align Technology presently has a consensus target price of $276.38, indicating a potential upside of 23.45%. Haemonetics has a consensus target price of $107.88, indicating a potential upside of 27.03%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts clearly believe Haemonetics is more favorable than Align Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 1 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.40Haemonetics 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 Do insiders & institutionals have more ownership in ALGN or HAE? 88.4% of Align Technology shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 0.6% of Align Technology shares are held by company insiders. Comparatively, 1.8% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor ALGN or HAE? In the previous week, Haemonetics had 4 more articles in the media than Align Technology. MarketBeat recorded 12 mentions for Haemonetics and 8 mentions for Align Technology. Align Technology's average media sentiment score of 1.22 beat Haemonetics' score of 0.86 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ALGN or HAE? Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500. SummaryAlign Technology beats Haemonetics on 10 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HAE vs. The Competition Export to ExcelMetricHaemoneticsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$4.26B$4.41B$5.01B$19.85BDividend YieldN/A41.16%5.16%3.52%P/E Ratio35.2424.82134.3742.73Price / Sales3.1347.021,158.6819.27Price / Cash14.7451.8733.5317.86Price / Book4.494.974.675.52Net Income$117.56M$13.76M$119.07M$986.45M7 Day Performance-6.42%-1.08%-1.83%0.45%1 Month Performance13.42%0.58%-3.62%1.05%1 Year Performance2.95%50.91%31.63%24.67% Haemonetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HAEHaemonetics4.925 of 5 stars$84.92+0.1%$107.88+27.0%+2.4%$4.26B$1.31B35.243,657ALGNAlign Technology4.6509 of 5 stars$223.87+0.6%$276.38+23.5%+4.0%$16.71B$3.96B38.2021,610Positive NewsMMSIMerit Medical Systems4.4368 of 5 stars$104.08-0.6%$103.36-0.7%+44.9%$6.10B$1.26B51.026,950Insider TradePositive NewsICUIICU Medical4.0342 of 5 stars$167.59-1.2%$173.00+3.2%+94.1%$4.15B$2.26B0.0014,000Analyst UpgradeShort Interest ↓XRAYDENTSPLY SIRONA4.8932 of 5 stars$18.52-1.9%$29.50+59.3%-38.1%$3.75B$3.97B0.0015,000Analyst DowngradeNEOGNeogen2.153 of 5 stars$14.90-1.3%$17.50+17.4%-8.5%$3.27B$924.22M-135.452,640QDELQuidelOrtho4.5813 of 5 stars$37.48-2.9%$58.83+57.0%-45.1%$2.59B$3.00B0.007,100Analyst ForecastGap DownHigh Trading VolumeSTAASTAAR Surgical4.8425 of 5 stars$26.32+0.7%$43.33+64.6%-24.3%$1.29B$322.42M59.821,115CERSCerus2.6525 of 5 stars$1.66-1.2%$3.63+118.4%-7.3%$312M$156.37M0.00625Positive NewsOSUROraSure Technologies4.4944 of 5 stars$3.81-1.3%$6.67+75.0%-47.2%$287.93M$405.47M25.40638ANIKAnika Therapeutics2.8624 of 5 stars$17.18+0.8%$24.50+42.6%-16.6%$249.57M$164.17M-2.58357High Trading Volume Related Companies and Tools Related Companies Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Neogen Alternatives QuidelOrtho Alternatives STAAR Surgical Alternatives Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HAE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HAE Stock Alerts